SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Orchid Pharma recognised as 'Three Star Export House'

08 Apr 2022 Evaluate

Orchid Pharma has been recognised as a Three Star Export House by the Ministry of Commerce & Industry, Government of India and felicitated with a Three Star Export House Recognition Certificate in accordance with the provisions of the Foreign Trade Policy 2015-2020. The aforesaid certificate shall be valid for a period of five years. The aforesaid recognition will aid in easier facilitation of various export licensing norms, various export-related benefits and self-recognition among the category of export Houses.

Orchid Pharma, established as an export-oriented unit (EOU), is a vertically integrated company spanning the entire pharmaceutical value chain from discovery to delivery with established credentials in research, manufacturing and marketing.

Orchid Pharma Share Price

1007.85 -42.85 (-4.08%)
10-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1935.25
Dr. Reddys Labs. 1245.50
Cipla 1438.75
Zydus Lifesciences 1150.50
Lupin 2496.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: